Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Dmac News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Dmac. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Dmac Today - Breaking & Trending Today

Head to Head Contrast: DiaMedica Therapeutics (NASDAQ:DMAC) and 9 Meters Biopharma (NASDAQ:NMTR) - Vimarsana News

Head to Head Contrast: DiaMedica Therapeutics (NASDAQ:DMAC) and 9 Meters Biopharma (NASDAQ:NMTR)

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Analyst Ratings This is a breakdown of current […]

Analyzing 9 Meters Biopharma (NASDAQ:NMTR) and DiaMedica Therapeutics (NASDAQ:DMAC) - Vimarsana News

Analyzing 9 Meters Biopharma (NASDAQ:NMTR) and DiaMedica Therapeutics (NASDAQ:DMAC)

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation. Volatility & Risk DiaMedica Therapeutics has a beta […]

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Up 55.6% in March - Vimarsana News

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Up 55.6% in March

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 91,500 shares, an increase of 55.6% from the March 15th total of 58,800 shares. Based on an average daily trading volume, of 31,800 shares, […]

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Insider David J. Wambeke Purchases 468,750 Shares - Vimarsana News

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Insider David J. Wambeke Purchases 468,750 Shares

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) insider David J. Wambeke purchased 468,750 shares of the company’s stock in a transaction dated Monday, April 10th. The stock was acquired at an average price of $1.60 per share, with a total value of $750,000.00. Following the completion of the transaction, the insider now owns 468,750 shares […]

DiaMedica Therapeutics (NASDAQ:DMAC) Posts Quarterly Earnings Results - Vimarsana News

DiaMedica Therapeutics (NASDAQ:DMAC) Posts Quarterly Earnings Results

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) posted its quarterly earnings results on Tuesday. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14), Yahoo Finance reports. During the same quarter in the previous year, the company earned ($0.10) EPS. DiaMedica Therapeutics Stock Performance DMAC stock opened at $1.52 on Wednesday. The […]

Source: wkrb13.com